Devrim Çabuk
Impact in
-
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
-
- Cancer Genomics and Diagnostics
Papers in
-
- Lung Cancer Treatments and Mutations 5
- Advanced Breast Cancer Therapies 4
- Gastric Cancer Management and Outcomes 3
- Oncology 14
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 4
- Cancer Treatment and Pharmacology 2
- Co-authors
- Kazım Uygun (17 shared papers)Umut Kefeli (8 shared papers)Faysal Dane (7 shared papers)Atalay Doğru (1 shared paper)Hasan Şenol Çoşkun (4 shared papers)Nazım Serdar Turhal (6 shared papers)Tayfun Şahı̇n (1 shared paper)Levent Korkmaz (3 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)ESMO Open (2 papers)Journal of Clinical Medicine (2 papers)Medicine (1 paper)Journal of Biotechnology (1 paper)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Devrim Çabuk
33 papers receiving 194 citations
Peers
Comparison fields: 5 of 49
- Oncology 57
- Cancer Research 28
- Cellular and Molecular Neuroscience 26
- Cardiology and Cardiovascular Medicine 26
- Endocrinology, Diabetes and Metabolism 19
Countries citing papers authored by Devrim Çabuk
This map shows the geographic impact of Devrim Çabuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devrim Çabuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devrim Çabuk more than expected).
Fields of papers citing papers by Devrim Çabuk
This network shows the impact of papers produced by Devrim Çabuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devrim Çabuk. The network helps show where Devrim Çabuk may publish in the future.
Co-authors
The 25 scholars most cited alongside Devrim Çabuk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 34 | |
| 2 | 2013 | 18 | |
| 3 | 2019 | 18 | |
| 4 | 2018 | 16 | |
| 5 | 2014 | 12 | |
| 6 | 2013 | 12 | |
| 7 | 2023 | 11 | |
| 8 | 2014 | 11 | |
| 9 | 2014 | 10 | |
| 10 | 2021 | 8 | |
| 11 | The distribution of CD44+/CD24- cancer stem cells in breast cancer and its relationship with prognostic factors. | 2017 | 6 |
| 12 | 2018 | 6 | |
| 13 | 2009 | 5 | |
| 14 | 2023 | 3 | |
| 15 | 2016 | 3 | |
| 16 | The prognostic value of β-catenin and LEF-1 expression in patients with operable gastric carcinoma. | 2016 | 3 |
| 17 | 2024 | 3 | |
| 18 | 2025 | 2 | |
| 19 | Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study. | 2011 | 2 |
| 20 | 2013 | 2 |
About Devrim Çabuk
Devrim Çabuk is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 39 papers that have together received 198 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Advanced Breast Cancer Therapies (4 papers), HER2/EGFR in Cancer Research (4 papers), Gastric Cancer Management and Outcomes (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers), Cancer Treatment and Pharmacology (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Oncology (57 citations), Cancer Research (28 citations), Cellular and Molecular Neuroscience (26 citations), Cardiology and Cardiovascular Medicine (26 citations) and Endocrinology, Diabetes and Metabolism (19 citations). Devrim Çabuk has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Kazım Uygun, Umut Kefeli, Faysal Dane, Atalay Doğru, Hasan Şenol Çoşkun, Nazım Serdar Turhal, Tayfun Şahı̇n, Levent Korkmaz, Mahmut Gümüş and Mustafa Karaağaç. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Journal of Clinical Medicine, Medicine and Journal of Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.